Anti-ZNF706 monoclonal antibody

Pre-made anti-ZNF706 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZNF706/ZNF706 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2843-Ab-1/ GM-Tg-hg-IP2843-Ab-2Anti-Human ZNF706 monoclonal antibodyHuman
GM-Tg-rg-IP2843-Ab-1/ GM-Tg-rg-IP2843-Ab-2Anti-Rat ZNF706 monoclonal antibodyRat
GM-Tg-mg-IP2843-Ab-1/ GM-Tg-mg-IP2843-Ab-2Anti-Mouse ZNF706 monoclonal antibodyMouse
GM-Tg-cynog-IP2843-Ab-1/ GM-Tg-cynog-IP2843-Ab-2Anti-Cynomolgus/ Rhesus macaque ZNF706 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2843-Ab-1/ GM-Tg-felg-IP2843-Ab-2Anti-Feline ZNF706 monoclonal antibodyFeline
GM-Tg-cang-IP2843-Ab-1/ GM-Tg-cang-IP2843-Ab-2Anti-Canine ZNF706 monoclonal antibodyCanine
GM-Tg-bovg-IP2843-Ab-1/ GM-Tg-bovg-IP2843-Ab-2Anti-Bovine ZNF706 monoclonal antibodyBovine
GM-Tg-equg-IP2843-Ab-1/ GM-Tg-equg-IP2843-Ab-2Anti-Equine ZNF706 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2843-Ab-1/ GM-Tg-hg-IP2843-Ab-2; GM-Tg-rg-IP2843-Ab-1/ GM-Tg-rg-IP2843-Ab-2;
GM-Tg-mg-IP2843-Ab-1/ GM-Tg-mg-IP2843-Ab-2; GM-Tg-cynog-IP2843-Ab-1/ GM-Tg-cynog-IP2843-Ab-2;
GM-Tg-felg-IP2843-Ab-1/ GM-Tg-felg-IP2843-Ab-2; GM-Tg-cang-IP2843-Ab-1/ GM-Tg-cang-IP2843-Ab-2;
GM-Tg-bovg-IP2843-Ab-1/ GM-Tg-bovg-IP2843-Ab-2; GM-Tg-equg-IP2843-Ab-1/ GM-Tg-equg-IP2843-Ab-2
Products NameAnti-ZNF706 monoclonal antibody
Formatmab
Target NameZNF706
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZNF706 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2843-Ag-1Recombinant multi-species ZN706/ ZNF706/ HSPC038 protein


    Target information

    Target IDGM-IP2843
    Target NameZNF706
    Gene ID51123,68036,500855,710457,607293,109496133,614279,100629307
    Gene Symbol and Synonyms3110006P09Rik,HSPC038,PNAS-106,PNAS-113,Zfp706,ZNF706
    Uniprot AccessionQ9Y5V0
    Uniprot Entry NameZN706_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000120963
    Target ClassificationN/A

    The target: ZNF706, gene name: ZNF706, also named as HSPC038, PNAS-106, PNAS-113. Predicted to enable metal ion binding activity. Predicted to be involved in negative regulation of stem cell population maintenance and negative regulation of transcription, DNA-templated. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.